Cell line · CVCL_0159
Papers239
12 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 239
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 43000531 | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Isolation, Structural Elucidation, and Anti-Melanogenic Activity of a Novel Pectic Polysaccharide From Alhagi camelorum Fisch. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Double coordination-driven Fe-DOX synergy enhances ferroptosis and immunogenic cancer therapy. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ruthenium(II) Carbosilane Dendrimers With Aliphatic Polyamine Ligands for In Vivo Antimelanoma Activity. | Bioinorg Chem Appl | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy. | Nat Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| On-demand design of controlled-release systems using an expert-mimic AI framework. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Focal therapeutic conditions matter: How energy affects antigen presentation and T cell activation. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Protective Effects of Duchesnea chrysantha Ethanol Extract Against UVB-Induced Skin Damage via Modulation of TAK1-Associated Signaling Pathways. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Deep Learning-Based Quantification of Spontaneous Pain Behaviours in Mice. | Eur J Pain | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Erk/CREB Signaling Axis Mediates G-CSF-Promoted G-MDSC Survival in the Peripheral Blood of Melanoma-Bearing Mice. | Biology (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. | J Exp Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer. | Mater Today Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Surface display of co-stimulatory ligand B7H2 on engineered bacteria enhances tumor immunotherapy. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bioactive Properties of Achillea biserrata M.Bieb. Extracts: Phytochemical Analysis, Antioxidant Activity, Target Enzyme Inhibition, and Cytotoxic Effects. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Neutralizing the IL12/IL23 p40 Subunit Prevents Immune Checkpoint Blockade Toxicity without Compromising Antitumor Efficacy. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer. | Biomolecules | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cblb Gene Editing in T Cells Sustains Expansion and Immunogenic CAR T Tumor Killing Under Chronic Antigenic Stimulation. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0159/papers